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Abstract. Proposed interventions for eliminating drug-resistant Plasmodium falciparummalaria include the targeting
of asymptomatic carriers through screening and treatment. We report on the diagnostic performance of the recently
developed ultrasensitive rapid diagnostic test (uRDT) compared with screening with conventional RDTs (cRDT) and
polymerase chain reaction (PCR) under ﬁeld conditions in Cambodia in a total of 2,729 individuals. The P. falciparum
positivity by quantitative PCR (qPCR) was 3.8% (26/678) in those screened during active case detection and 0.5%
(10/2,051) in the cross-sectional survey. Compared with qPCR, the sensitivity of the uRDTs was 53.8% (95% CI:
33.4–73.4%)when used in active case detection and 60.0% (95%CI: 26.2–87.8%) in the cross-sectional survey. The
uRDTs did not show a signiﬁcant improvement in diagnostic performance over cRDTs when used for active case
detection and for a malaria prevalence survey in the context of this low-transmission setting.
Like elsewhere in Southeast Asia, the burden of malaria
in Cambodia has decreased dramatically over the last
15 years.1,2 However, the region is under the threat of Plas-
modium falciparum resistance to artemisinin-based combi-
nation therapy.3 The Royal Government of Cambodia has
committed to eliminatingP. falciparummalaria by 2020 and all
forms of malaria by 2025.4 Neighboring countries including
Thailand, Vietnam, and Laos have also committed to malaria
elimination.
To eliminate P. falciparum malaria, treatment strategies
that solely focused on patients presenting with symptomatic
malaria are unlikely to be sufﬁcient. Asymptomatic carriage
with low-level parasitaemias has now been well documented
in the region and represents an important potential reservoir
of infection.5
Until recently, efforts to screen for low-density infections
have been limited by the available diagnostics. Conventional
rapid diagnostic tests (cRDTs), although easy to use in the
ﬁeld and sufﬁciently sensitive for conﬁrming infection in
symptomatic infections, are not sensitive enough to detect
low-level parasitaemias in asymptomatic infections. Con-
versely, molecular diagnosis using polymerase chain reaction
(PCR) is highly sensitive but requires sophisticated laboratory
facilities and, therefore, cannot be used operationally as a
screening tool in remote forested areaswhere populations at a
risk of malaria infection live.6–8
New “ultrasensitive rapid diagnostic tests” (uRDTs) have
recently been developed and offer the exciting potential of a
ﬁeld-deployable highly sensitive test. Similar to cRDTs, they
are based on the immunodetection of histidine-rich protein
2 (HRP2); however, they have a reported sensitivity of more
than 50%withP. falciparum densities between 0.1 and 1 p/μL
under laboratory conditions.9 Although promising, this new
test needs to be evaluated under ﬁeld conditions to determine
its potential performance and utility in malaria elimination
programs.
We aimed to evaluate the performance of uRDT in com-
parison with a cRDT and quantitative PCR (qPCR) under ﬁeld
conditions on the Cambodian–Thai border.
This study was nested within a large study of active case
detection for malaria, which was carried out in Oddar
Meanchey Province in Northwest Cambodia. In brief, in the
65 villages in the intervention arm, active case detection
was carried out both reactively and proactively. Reactive
case detection was carried out around “index cases,” that
is, patientswith symptomaticP. falciparummalariawho had
presented to a village malaria worker or health center.
Screening for malaria was carried out on members of their
household, individuals who had traveled to the forest with
them (“co-travelers”), and “high-risk” neighbors. High-risk
individuals were deﬁned as anyone reporting to have slept
overnight in the forest in the past month and any individual
with a reported fever in the previous 48 hours. In proactive
case detection, all high-risk individuals in villages with high
number of P. falciparum cases were screened proactively.
From June to December 2017, screening for malaria was
carried out using three diagnostic tests: uRDT (Alere Malaria
Ag P.f, Abbott, Lake Bluff, IL), cRDT under routine use (Stan-
dard Diagnostics, Bioline) with HRP-II and pLDH antigen RDT
(Alere Malaria Ag P.f, Abbott), and nested PCR on blood spot
samples conducted at the Institute Pasteur laboratory in
Phnom Penh, as previously described.10 In addition, a cross-
sectional surveywas conducted fromNovember toDecember
2017 in 17of the highest burden villages. All participants found
positive for malaria by any diagnostic tests were offered
treatment with the ﬁrst-line ACT.
Both village malaria workers and survey data collectors
were providedwith training on how to take blood samples and
carry out RDTs correctly as well as preparing ﬁlter paper and
preprepared 96-well plates for subsequent PCR analysis.
Nucleic material extraction from dried blood spot and
screening for any malaria species infection and then speciﬁc
P. falciparum infection were carried out according to the
methodology of Canier et al.11 Results of RDTswere recorded
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on paper-based forms by ﬁeld workers, uploaded into an
Excel (Microsoft Corporation, Redmond, WA) database,
and then merged with the results of qPCR analysis using
the unique participant identiﬁcation number. The de-
scriptive statistical analysis was carried out using Stata
15.1 (StataCorp, College Station, TX). Using qPCR as the
reference standard, sensitivity and speciﬁcity were cal-
culated. As the main target population for malaria control
and elimination in this region is forest goers, a subgroup
analysis was carried out on this group, deﬁned as anyone
who had reportedly slept overnight in the forest in the
previous month.
Ethical approval for this study was obtained from the
Cambodian National Ethical Committee for Human Research
and the London School of Hygiene & Tropical Medicine Ethics
Committee. Participants were included in the study only if
informed consent was obtained (parents or guardians pro-
vided consent for children younger than 18 years). Children
older than 12 years were also required to provide oral assent
for participation in addition to the consent of their parent or
guardian.
In total, 2,729 individuals were tested using all three
diagnostic tests: 678 during active case detection and
2,051 during the cross-sectional survey. The positivity
rate for P. falciparum infections by qPCR analysis was
3.8% (26/678) and 0.5% (10/2,051) for active case de-
tection and the cross-sectional survey, respectively. The
cRDT and uRDT results were compared with the qPCR
results as the reference standard (Table 1). When used for
active case detection, the sensitivity of the cRDT and
uRDT for P. falciparum malaria was 46.2% (95% CI:
26.6–66.6%) and 53.8% (95% CI: 33.4–73.4%) and
speciﬁcity was 98.2% (95% CI: 96.8–99.0%) and 96.8%
(95% CI: 95.1–98.0%), respectively (P = 0.0127). Ten
samples were positive by qPCR and negative by both
types of RDTs and 11 samples were negative by qPCR
but positive by both types of RDTs. When used in the
cross-sectional survey, the sensitivity for P. falciparum
was 60.0% (95% CI: 26.2–87.8%) and speciﬁcity was
99.8% (95% CI: 99.5–99.9%) for both cRDT and uRDTs
compared with the reference PCR (P = 1). Four samples
tested positive by qPCR and negative by both RDTs and
vice versa. Figure 1 shows the parasite densities by the
RDT result. Sub-analysis conducted on just forest goers
showed similar ﬁndings (results not shown).
To our knowledge, this is the ﬁrst published study to re-
port on the diagnostic performance of uRDTs under ﬁeld
conditions. The uRDTs were found to have similar sensi-
tivity and speciﬁcity to both cRDTs when used in active
case detection and in a cross-sectional survey. This differs
from what has been reported from laboratory-based stud-
ies. Das et al.9 reported a uRDT sensitivity of 44% (95% CI:
15–77%) and speciﬁcity of 99.8% (95% CI: 99–100%)
compared with quantitative reverse transcriptase PCR
(qRT-PCR) and compared with a sensitivity of 0% (95% CI:
0–37%) and a speciﬁcity of 100% (95% CI: 99–100%) for
the cRDT (Bioline, Standard Diagnostics) in whole blood
specimens collected from asymptomatic individuals in a
cross-sectional survey in Myanmar, where the positivity
was 1.8% (9 of 493) by qRT-PCR. An analysis of 247 blood
TABLE 1
Comparison between PCR and cRDTs and uRDTs for screening for
Plasmodium falciparum during active case detection and the cross-
sectional survey
cRDT+ cRDT− uRDT+ uRDT−
Active case detection
Total 24 654 35 643
PCR Pf+ 12 14 14 12
PCR Pf− 12 640 21 631
Sensitivity (%) 46.2 (95% CI:
26.6–66.6%)
53.8 (95% CI:
33.4–73.4%)
Speciﬁcity (%) 98.2 (95% CI:
96.8–99.0%)
96.8 (95% CI:
95.1–98.0%)
Cross-sectional survey
Total 10 2,041 10 2,041
PCR Pf+ 6 4 6 4
PCR Pf− 4 2,037 4 2,037
Sensitivity (%) 60.0 (95% CI:
26.2–87.8%)
60.0 (95% CI:
26.2–87.8%)
Speciﬁcity (%) 99.8 (95% CI:
99.5–99.9%)
99.8 (95% CI:
99.5–99.9%)
cRDT = conventional rapid diagnostic test; PCR = polymerase chain reaction;
Pf = Plasmodium falciparum; uRDT = ultrasensitive rapid diagnostic test.
FIGURE 1. Distribution of estimated parasite density calculated from polymerase chain reaction cycle threshold levels, in comparison with
conventional rapid diagnostic tests (RDTs) and ultrasensitive RDTs (uRDTs) for screening for Plasmodium falciparum during active case detection
and cross-sectional survey in Cambodia.
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samples from a cross-sectional survey in Papua New
Guinea by Hofmann et al.12 reported a uRDT (Malaria Ag P.f
Ultra-Sensitive, Standard Diagnostics) sensitivity of 27%
compared with 15% for cRDTs (Malaria Ag P.f/P.v, Stan-
dard Diagnostics) with qPCR used as a reference method.
It should be noted that the PCR techniques used differed
between studies andmay explain some of the differences in
the results.
There are a number of reasons why the uRDTs did not show
enhanced sensitivity compared with cRDTs in this study. The
uRDTs were stored in an air-conditioned ofﬁce; however, it is
possible that for brief periods during power cuts and trans-
portation, theymay have been exposed to temperatures of up
to 35C—higher than the recommended maximum of 30C.
Incorrect use by the ﬁeld workers is also possible but very
unlikely, as they received extensive training, were closely su-
pervised and worked in pairs so that two people checked the
results. A ﬁnal consideration is the possibility of HRP2 dele-
tions; however, this has not yet been reported in the region.
Despite their reported enhanced sensitivity, uRDTs did not
show a signiﬁcant improvement in diagnostic performance
overcRDTswhenused foractivecasedetectionand foramalaria
prevalence survey in the context of this low-transmission setting.
Further ﬁeld evaluations for uRDTs are required in different epi-
demiological andunderdifferent operational settings to establish
where they are likely to be of most beneﬁt.
Received May 6, 2019. Accepted for publication October 1, 2019.
Acknowledgments: We thank warmly all the study participants, ﬁeld
teams, village malaria workers, and health center staff. We also thank
Alere for donating uRDTs for the study.
Financial support: This work is funded by the United Kingdom Depart-
ment for International Development (UKAID, agreement PO 5408).
Authors’ addresses: Shunmay Yeung, David McGregor, and Nicola
James, Clinical Research Department, Faculty of Infectious and Tropical
Disease, Malaria Centre, London School of Hygiene and Tropical Medi-
cine, London, United Kingdom, E-mails: shunmay.yeung@lshtm.ac.uk,
mcgregor1@lshtm.ac.uk, andnicola.h.james@gmail.com.SoyTyKheang,
Health and Social Development (HSD), Phnom Penh, Cambodia, E-mail:
ksoyty@urc-chs.com. Saorin Kim, Nimol Khim, and Benoit Witkowski,
Institut Pasteur du Cambodge, Phnom Penh, Cambodia, E-mails:
ksaorin@pasteur-kh.org, knimol@pasteur-kh.org, and bwitkowski@
pasteur-kh.org. Po Ly and Siv Sovannaroth, National Center for Para-
sitology, Entomology and Malaria Control, Phnom Penh, Cambodia,
E-mails: polyteng168@gmail.com and sivsovannaroths@gmail.com.
This is an open-access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the
original author and source are credited.
REFERENCES
1. Sochantha T, Hewitt S, Nguon C, Okell L, Alexander N, Yeung S,
Vannara H, Rowland M, Socheat D, 2006. Insecticide-treated
bednets for the prevention ofPlasmodium falciparummalaria in
Cambodia: a cluster-randomized trial. Trop Med Int Health 11:
1166–1177.
2. WHO, 2018. World Malaria Report 2018. Geneva, Switzerland:
World Health Organization.
3. AshleyEAet al.; TrackingResistance toArtemisininCollaboration,
2014. Spread of artemisinin resistance in Plasmodium falcipa-
rummalaria. N Engl J Med 371: 411–423.
4. Ministry of Health Kingdom of Cambodia, 2017. Cambodia
Malaria Elimination Action Framework (2016–2020) j MESA.
Available at: http://mesamalaria.org/resource-hub/cambodia-
malaria-elimination-action-framework-2016-2020. Accessed
October 1, 2019.
5. Bousema T, Okell L, Felger I, Drakeley C, 2014. Asymptomatic
malaria infections: detectability, transmissibility and public
health relevance. Nat Rev Microbiol 12: 833–840.
6. Gryseels C et al., 2015. High mobility and low use of malaria
preventive measures among the Jarai male youth along the
Cambodia-Vietnam border. Am J Trop Med Hyg 93: 810–818.
7. Guyant P, Canavati SE, Chea N, Ly P,WhittakerMA, Roca-Feltrer
A, Yeung S, 2015. Malaria and the mobile and migrant pop-
ulation in Cambodia: a populationmovement framework to inform
strategies for malaria control and elimination.Malar J 14: 252.
8. Bannister-Tyrrell M et al., 2019. Forest goers and multidrug-
resistant malaria in Cambodia: an ethnographic study. Am J
Trop Med Hyg 100: 1170–1178.
9. Das S et al., 2017. Performance of a high-sensitivity rapid diag-
nostic test for Plasmodium falciparum malaria in asymptom-
atic individuals from Uganda and Myanmar and naive human
challenge infections. Am J Trop Med Hyg 97: 1540–1550.
10. Hoyer S et al., 2012. Focused screening and treatment (FSAT): a
PCR-based strategy to detect malaria parasite carriers and
contain drug resistant P. falciparum, Pailin, Cambodia. PLoS
One 7: e45797.
11. Canier L et al., 2015. Malaria PCR detection in Cambodian low-
transmission settings: dried blood spots versus venous blood
samples. Am J Trop Med Hyg 92: 573–577.
12. Hofmann NE et al., 2018. Assessment of ultra-sensitive malaria
diagnosis versus standard molecular diagnostics for malaria
elimination: an in-depth molecular community cross-sectional
study. Lancet Infect Dis 10: 1108–1116.
ULTRA SENSITIVE RDT IN CAMBODIA 3
